USP Small Molecules

(Saxagliptin amide analogue (1S,3S,5S)-2-{(S)-2-amino-2-[(1r,3R,5R,7S)-3-hydroxyadamantan-1-yl]acetyl}-2-azabicyclo[3.1.0]hexane-3-carboxamide)

(Saxagliptin pyrazine analog (1aS,4S,6aR,7aS)-6-amino-4-[(1r,3R,5R,7S)-3-hydroxyadamantan-1-yl]-1,1a,4,6a,7,7a-hexahydro-3H-cyclopropa[4,5]pyrrolo[1,2-a]pyrazin-3-one)

(1,4-dideoxy-1,4-dihydro-3-[[[4-methyl-1-piperazinyl]imino]methyl]-1,4-dioxo-rifamycin)

(alpha-Methyl-5H-[1]benzopyrano[2,3-b]pyridine-7-ylacetic acid)

(Calcium (S,4E,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3-hydroxyhepta-4,6-dienoate)

((4R,6S)-6-{(E)-2-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]vinyl}-4-hydroxytetrahydro-2H-pyran-2-one)

(Calcium (3SR,5SR,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate)

((2RS,6RS,11RS)-8-Hydroxy-6,11-dimethyl-3-(3-methylbut-2-en-1-yl)-1,2,3,4,5,6-hexahydro-2,6-methanobenzo[d]azocine N-oxide)

((2RS,6RS,11RS)-3-(3-Hydroxy-3-methylbutyl)-6,11-dimethyl-1,2,3,4,5,6-hexahydro-2,6-methanobenzo[d]azocin-8-ol)

((2RS,6RS,11RS)-6,11-dimethyl-1,2,3,4,5,6-hexahydro-2,6-methanobenzo[d]azocin-8-ol)

(1-Cyclopropyl-1,4-dihydro-8-methyl-7-[5-methyl-6-(methylamino)-3-pyridinyl]-4-oxo-3-quinolinecarboxylic acid)

(4-Hydroxy-2-oxo-1-pyrrolidineacetamide)

((R)-4-(2-Amino-1-methoxyethyl)benzene-1,2-diol bitartrate hydrate)

(3-(Dimethylamino)phenol)

(3-Hydroxy-N,N,N-trimethylbenzenaminium bromide)

(4-(2-Methoxyphenyl)-alpha-[(1-naphthalenyloxy)methyl]-1-piperazineethanol)